The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
- PMID: 8391303
- PMCID: PMC1968291
- DOI: 10.1038/bjc.1993.306
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
Abstract
Increased expression of epidermal growth factor receptor (EGFr) has been reported in non small cell lung cancers (NSCLC) when compared to normal lung. We have examined post-operative survival in 19 surgically treated patients with NSCLC who had full characterisation of EGFr on primary tumour membrane preparations from resection specimens. There were ten squamous, seven adeno and two large cell carcinomas. The median concentration of high affinity sites was 31 fmol per mg of protein (4-1532) and the median dissociation constant (Kd) of these high affinity sites was 2.3 x 10(-10) per mol (1.2-30 x 10(-10)). Seven patients survived over 5 years. Twelve patients died between 8.5 and 55 months from the time of surgery. When > 5 year survivors were compared to non-survivors there was no difference as regards tumour size or stage, or as regards age or sex. The survivors had a median concentration of high affinity EGFr sites of 16.1 fmol mg-1 protein compared to a median concentration of 68.6 fmol mg-1 protein in the non-survivors (P = 0.01 Wilcoxon test). No long term survivor had > 35 fmol mg-1 protein of receptor. Thus EGFr quantitation may give independent prognostic information in NSCLC and help to select patients for adjuvant therapy after surgery. These results need confirmation in a larger prospective study.
Similar articles
-
High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.Clin Lung Cancer. 2014 Jan;15(1):58-66. doi: 10.1016/j.cllc.2013.08.005. Epub 2013 Nov 7. Clin Lung Cancer. 2014. PMID: 24210543
-
The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.Swiss Med Wkly. 2013 Sep 6;143:w13855. doi: 10.4414/smw.2013.13855. eCollection 2013. Swiss Med Wkly. 2013. PMID: 24018850 Review.
-
Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.Clin Lung Cancer. 2006 May;7(6):395-400. doi: 10.3816/CLC.2006.n.023. Clin Lung Cancer. 2006. PMID: 16800965
-
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis.Eur Respir J. 2002 Oct;20(4):975-81. doi: 10.1183/09031936.02.00296502. Eur Respir J. 2002. PMID: 12412692 Review.
-
Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.Oncol Rep. 2000 May-Jun;7(3):603-7. doi: 10.3892/or.7.3.603. Oncol Rep. 2000. PMID: 10767376
Cited by
-
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.
-
Himalayan flora: targeting various molecular pathways in lung cancer.Med Oncol. 2023 Oct 3;40(11):314. doi: 10.1007/s12032-023-02171-x. Med Oncol. 2023. PMID: 37787816 Review.
-
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.Molecules. 2023 May 8;28(9):3974. doi: 10.3390/molecules28093974. Molecules. 2023. PMID: 37175381 Free PMC article.
-
Long Non-coding RNA snaR Promotes Proliferation in EGFR Wild Type Non-Small Cell Lung Cancer Cells.Int J Mol Cell Med. 2021 Fall;10(4):258-264. doi: 10.22088/IJMCM.BUMS.10.4.258. Epub 2022 Jun 6. Int J Mol Cell Med. 2021. PMID: 35875332 Free PMC article.
-
Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer.Biomed Res Int. 2022 Jan 20;2022:2698190. doi: 10.1155/2022/2698190. eCollection 2022. Biomed Res Int. 2022. PMID: 35097114 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous